FOXP3 and ovarian carcinoma: Our study provides compelling evidence that the modulation of FOXP3 gene expression in OVCAR3 cells by rosmarinic acid and doxorubicin represents a promising avenue for enhancing therapeutic strategies against ovarian cancer.